SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-020331
Filing Date
2020-11-02
Accepted
2020-11-02 16:26:05
Documents
11
Period of Report
2020-10-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 52989
2 ex1-1.htm EX-1.1 217453
3 ex4-1.htm EX-4.1 124743
4 ex5-1.htm EX-5.1 12223
5 ex23-2.htm EX-23.2 1016
6 ex99-1.htm EX-99.1 13795
7 ex99-2.htm EX-99.2 10299
8 ex99-3.htm EX-99.3 11510
9 ex23-2_001.jpg GRAPHIC 35072
10 ex99-1_001.jpg GRAPHIC 5005
11 ex99-2_001.jpg GRAPHIC 5001
  Complete submission text file 0001493152-20-020331.txt   507763
Mailing Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070
Business Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070 201.528.9200
CANCER GENETICS, INC (Filer) CIK: 0001349929 (see all company filings)

IRS No.: 043462475 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35817 | Film No.: 201280768
SIC: 8071 Services-Medical Laboratories